Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zinforo (ceftaroline fosamil) for the Treatment of Complicated Skin and Soft Tissue Infections

Drug (Brand / Generic)

Zinforo / ceftaroline fosamil

Company / Licensee

Astra Zeneca / Forest Laboratories

Therapy Class

Cephalosporin antibiotic

Current Indication

Complicated Skin and Soft Tissue Infections (cSSTI) or Community Acquired Pneumonia (CAP)

Market Sector

Anti-infectives

Development Status

Approved in Europe
Expand

Go Top